PS Channel

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
LLY Description — Lilly (Eli) & Co

Eli Lilly & Company is engaged in discovering, developing, manufacturing, and marketing products in two business segments: human pharmaceutical products and animal health products. Co.'s human pharmaceutical products include: endocrinology products, neurosciences products, oncology products, and cardiovascular products. Co.'s animal health products are comprised of products for animals, which include Rumensin, a cattle feed additive, and Tylan, an antibiotic used to control certain diseases in cattle, swine, and poultry; as well as products for companion animals, which include Trifexis and Comfortis, a chewable tablet that kills fleas and prevents flea infestations on dogs.

Company Name: Lilly (Eli) & Co
Sector: Drugs & Pharmaceuticals
Number of ETFs Holding LLY: 104
Total Market Value Held by ETFs: $6,834,325,381.08
Total Market Capitalization: $84,476,000,000
% of Market Cap. Held by ETFs: 8.09%
ETF LLY Weight LLY Amount
VTI 0.28% $1,798,805,371
VOO 0.32% $1,247,117,453
SPY 0.31% $871,527,045
IVV 0.32% $479,479,970
VTV 0.59% $384,278,368
XLV 2.19% $365,797,960
IWF 0.56% $222,600,075
VYM 0.73% $212,808,154
VHT 2.01% $165,482,910
DVY 0.94% $158,550,140
List of all 104 ETFs holding LLY ยป
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
25 Dividend Giants Widely Held By ETFs
25 S.A.F.E. Dividend Stocks Increasing Payments For Decades
Broker Darlings: Top 15 Analyst Picks of the Dow
Top 25 Broker Analyst Picks of the S&P 500
Forgotten S&P 500 Giants: Analysts' Current Least Favorites
25 Top Ranked Socially Responsible Dividend Stocks
10 Oversold ETFs

10 ETFs Crossing Above Their 200 DMA
The 10 Biggest ETFs
The 10 Best ETF Performers
The 10 Worst ETF Performers
10 ETFs With Notable Inflows
10 ETFs With Notable Outflows
Top 10 Analyst Rated Consumer Stocks
Top 10 Analyst Rated Healthcare Stocks
Top 10 Analyst Rated Technology Stocks

Quotes delayed 20 minutes

Buy (2.76 out of 4)
29th percentile
(ranked lower than approx. 71% of all stocks covered)

Analysts Forecast:
LLY Price Target

Based on


Fri, Feb 9, 10:00 AM, Zacks

Although pharma ETFs saw terrible trading over the past one month in the latest global market rout, the string of earnings beat bolstered confidence in the space.

Wed, Feb 7, 9:23 AM, Zacks

Array's (ARRY) shares gain on impressive overall survival data from a phase III trial of combined binimetinib and encorafenib for BRAF-mutant advanced, unresectable or metastatic melanoma.

Top Finances News

toronto dominion bank stock price altria group stock price history blackrock municipal income trust ii nyse arca gold miners index components direxion daily large cap bear 3x shares top 50 dividend paying stocks guggenheim s&p 500 equal weight etf chicago bridge and iron stocks chicago bridge and iron history stock market symbol for sony stanley black and decker stock price history wolverine world wide stock price

ETFs Holding LLY | Lilly (Eli) & Co | PC Channel | | Copyright © 2009 - 2018, All Rights Reserved

Nothing in PC Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following and . and ETF videos powered by . Quote data delayed at least 20 minutes; , and . ; .